Stock data

麗豐-KY (4137)

麗豐-KY is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$478.82M, up 22.0% from a year earlier. EPS over the last four quarters totals NT$6.75.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 麗豐-KY in Insightr